| [1] |
Yun-fang MA, Li-na PAN, Zhen LI, Bei-li GAO, Jia-an HU, Zhi-hong XU.
Exploratory study on downregulation of PD-L1 in KRAS G12V-mutant non-small cell lung cancer cells by selumetinib
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 741-748.
|
| [2] |
Jian-hua XU, Ping JIANG, Jiong DENG.
Expression and significance of ATP-binding cassette superfamily G member 2 in lung cancer
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 830-833.
|
| [3] |
XU Shu-lin, WU Jing, LOU Jia-tao.
Correlation analysis of lung cancer and anemia
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1500-1504.
|
| [4] |
HE Chun-ming, YIN Hang, TANG Jian, DING Yi-zong, FU Yu-jie, ZHAO Xiao-jing.
Establishment and internal validation of a prognostic model for elderly patients after lung cancer surgery based on SEER
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1554-1561.
|
| [5] |
ZHOU Zhen, XU Yun-hua, ZHANG Fei-fei, ZHAO Yi, GUO Lin, FU Guo-long, SHEN Sheng-ping, LENG Xue-jiao.
Establishment of a lung cancer momodel with humanized immunity and its role in efficacy evaluation of programmed death-1 inhibitors
[J]. , 2020, 40(1): 37-.
|
| [6] |
ZOU Chen1, 2, XU Run-hao1, 3, ZHANG Hong2, MA Zhan2, CHEN Li2, ZHANG Jie3, LI Min3, ZHANG Shu-lin1.
Potential roles of small metabolites in the differential diagnosis between lung cancer and pneumonia
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(08): 1041-1047.
|
| [7] |
HE Chun-ming, YIN Hang, ZHENG Jia-jie, TANG Jian, FU Yu-jie, ZHAO Xiao-jing.
Immunotherapy for lung cancer: immunosuppressive cells and intrapulmonary immunity
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(08): 1137-1142.
|
| [8] |
QU Guo-jun1, LU Yuan-feng2, LI Yu1.
Mechanism of CCT2, a new downstream substrate of PDGFRα, on proliferation of tumor cells
[J]. , 2019, 39(1): 28-.
|
| [9] |
HE Ya-ping1, LOU Wei-qun2, CHEN Jie-ling2, ZHOU Zhen3, ZHU Jing-fen1, JIAN Hong3.
Influencing factors for quality of life in patients over 12 months after diagnosis of non-small cell lung cancer
[J]. , 2018, 38(7): 775-.
|
| [10] |
DAI Wei, WANG Xiao-wen, HUANG Chun, XIANG Xiao-yong, JIANG Yin-jiu, WU Qing-chen.
Research progress in the risk factors and mechanisms of postoperative atrial fibrillation after lung cancer surgery
[J]. , 2018, 38(5): 573-.
|
| [11] |
YU Huan1,LI Qing-yun2.
Research progress of the local treatments on choroidal metastasis of lung cancer
[J]. , 2018, 38(2): 233-.
|
| [12] |
WANG Ye, XIE Wang, ZHANG Jie, SHENG Jie-ying, GUO Zhong-liang.
Mechanism of hsa-miRNA124-3p regulating the proliferation and migration of human lung cancer cell line NCI-H460#br#
[J]. , 2017, 37(8): 1051-.
|
| [13] |
HU Zhang-guo, CAO Shu-hui, ZHONG Hua .
Efficacy of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients with uncommon EGFR 21L861Q mutation#br#
[J]. , 2017, 37(11): 1524-.
|
| [14] |
WAN Jian-wei, ZHOU Lin, ZHAO Dan-dan, YANG Yu-qin, LU Li-ming.
Effects of PHPO on apoptosis and proliferation of lung cancer cell line A549#br#
[J]. , 2017, 37(10): 1315-.
|
| [15] |
CHEN Lei, XIA Shu-yue.
Therapeutic effect and safety of bevacizumab combined with cisplatin on malignant pleural effusion of patients with non-small cell lung cancer
[J]. , 2015, 35(8): 1194-.
|
